Estrogen may improve pathway-selective insulin resistance

Estrogen may improve pathway-selective insulin resistance
Estrogen treatment at the time of surgical menopause may reverse aspects of pathway-selective insulin resistance in the liver associated with a high-fat diet in mice by promoting insulin action on glucose metabolism but limiting hepatic lipid deposition, according to a study published in the February issue of Diabetes.

(HealthDay)—Estrogen treatment at the time of surgical menopause may reverse aspects of pathway-selective insulin resistance in the liver associated with a high-fat diet (HFD) in mice by promoting insulin action on glucose metabolism but limiting hepatic lipid deposition, according to a study published in the February issue of Diabetes.

Lin Zhu, from the Tennessee Valley Healthcare System in Nashville, and colleagues tested whether given at the time of ovariectomy (OVX) in mice may alter the impact of HFD feeding. Insulin sensitivity, tracer incorporation into hepatic lipids, and liver triglyceride export were assessed with hyperinsulinemic-euglycemic clamps.

The researchers note that increased adiposity was seen in OVX mice, and was prevented with estradiol (E2) treatment at the time of OVX. Insulin sensitivity was increased with E2 treatment in mice with OVX and HFD. HFD feeding induced fatty liver, and insulin reduced hepatic apoB100 and liver triglyceride export in sham and OVX mice. Liver lipid deposition was reduced with E2 treatment, which also prevented the decrease in liver triglyceride export during hyperinsulinemia. In mice lacking the liver estrogen receptor α, E2 treatment after OVX reduced adiposity but did not improve insulin sensitivity, limit liver lipid deposition, or avert insulin suppression of export of liver triglycerides.

"In conclusion, estrogen treatment may reverse aspects of pathway-selective by promoting on but limiting hepatic lipid deposition," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Improving obesity-induced insulin sensitivity

Jun 01, 2012

In recent years, a growing body of evidence has linked inflammation to the development of insulin resistance. In insulin resistance, the hormone insulin is less effective in promoting glucose uptake from the bloodstream into ...

Recommended for you

Team shows why wound healing is impaired in diabetics

Jan 26, 2015

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.